Makes certain non-opioid prescription drugs used to manage chronic pain easier and cheaper for people on Medicare Part D. Starting for plan years on or after January 1, 2026, qualifying drugs will not be subject to the Part D deductible, must be placed on the lowest cost-sharing tier when calculating maximum coinsurance or cost‑sharing, and plans may not require patients to first try opioids (step therapy) or impose prior authorization for those drugs. The law also aligns low‑income subsidy rules with these changes.